KTOV might be trading close to $50 or beyond imo (less than $200m cap is very reasonable IMO) before the billion dollar Celebrex improved drug hit the market in 2017 .Kitov actually beats cpxx on all parameters and the last one trading 30 times Kitov's cap. Management; a former FDA officer and former Teva,Pfizer and more big names.